Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

Delayed Quote. Delayed  - 07/22 10:00:00 pm
689.37 USD   -0.23%
07/21 INTUITIVE SURGI : Top Medical Companies Reach High Financial Strengt..
07/20 INTUITIVE SURGI : Appropriate Balance Financial Services Lowers stak..
07/20 MARKETS RIGHT N : US stocks end higher, led by technology
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Intuitive Surgical, Inc. : Intuitive Surgical 1Q Profit Up 38% On Strong Revenue

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 12:14am CEST

--Intuitive Surgical tops first-quarter sales and earnings estimates

--Sales of da Vinci systems, procedure growth, fuel gains

--Company raises full-year guidance for sales, procedure growth

(Updates throughout with details on results and outlook)

 
   By Jon Kamp 
   Of  
 

Intuitive Surgical Inc.'s (ISRG) first-quarter earnings rose 38%, beating Wall Street expectations behind climbing sales of the company's da Vinci robotic-surgery machines and growth in procedures.

The Sunnyvale, Calif., company boosted its full-year forecasts for both revenue and procedure growth following the strong quarterly report. Shares--which are trading near all-time high levels and have climbed 18% on the year through Tuesday's close--rose 5.8%, to $576.98 in after-hours trading.

The company's motion-capture robots, which have been heavily used for cancer-treating surgeries, such as hysterectomies and prostate removal, have remained in strong demand despite continued economic turbulence and some sluggishness in Europe. The company sold 140 machines in the recent quarter, up 20 from a year ago, and posted 29% growth in procedures.

The company saw strong growth in both general-surgery and gynecological procedures, Chief Executive Gary Guthart said on a conference call with analysts. Newly introduced da Vinci instruments also helped fuel rising sales.

Intuitive Surgical reported a profit of $143.5 million, or $3.50 a share, up from $104.1 million, or $2.59 a share, a year earlier. Revenue increased 28%, to $495.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $3.14 on revenue of $464.7 million.

Gross margin edged up to 71.9% from 71.8%.

Revenue from instruments and accessories climbed 32%, reflecting growth in da Vinci procedures and the roll-out of new products. Revenue from service deals for da Vinci machines jumped 27%. Systems revenue, reflecting newly sold machines, grew 24%.

Da Vinci systems sold for nearly $1.5 million, on average, in the recent quarter.

Despite the overall strong sales, company officials said system sales in Europe were disappointing and below historical trends. They indicated the company is working to bolster its marketing efforts there.

"European system sales reflect a challenging economic environment, however, we are also taking steps to improve our execution," Chief Financial Officer Marshall Mohr said on the conference call.

Looking ahead, Intuitive Surgical now anticipates revenue growth of 19% to 21% this year, up from the company's prior 17% to 19% forecast. The company's new guidance calls for procedure growth of 25% to 27%, up from the prior 24% to 26% target.

Analysts had forecast, on average, sales growth of about 18% this year.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

--Tess Stynes contributed to this article.

Order free Annual Report for Intuitive Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US46120E6023 or call +44 (0)208 391 6028

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL, INC.
07/21 INTUITIVE SURGICAL : Top Medical Companies Reach High Financial Strength
07/20 INTUITIVE SURGICAL : Appropriate Balance Financial Services Lowers stake in Intu..
07/20 INTUITIVE SURGICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
07/20 MARKETS RIGHT NOW : US stocks end higher, led by technology
07/20 NASDAQ 100 MOVERS : Fox, isrg
07/20 S&P 500 MOVERS : Fcx, ctas
07/19DJINTUITIVE SURGICAL : Tops Expectations
07/19DJINTUITIVE SURGICAL : Tops Expectations
07/19 INTUITIVE SURGICAL : tops Street 2Q forecasts
07/19 INTUITIVE SURGICAL INC : Results of Operations and Financial Condition, Financia..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth
07/08 Medtech's 2016 stock surge confronts second-quarter test
06/21 PHILIPS : buys Northern Irish medical imaging company
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
07/20 Intuitive Surgical Q2 2016 Conference Key Takeaways
07/20 Zimmer Biomet Becomes The Latest Ortho To Go Robotic
07/20 Intuitive Surgical (ISRG) Gary S. Guthart on Q2 2016 Results - Earnings Call ..
07/19 After Hours Gainers / Losers
07/19 Intuitive Surgical Q2 top line up 14%; net income up 37%; shares ahead 5% aft..
Advertisement
Financials ($)
Sales 2016 2 643 M
EBIT 2016 1 013 M
Net income 2016 674 M
Finance 2016 1 447 M
Yield 2016 -
P/E ratio 2016 39,38
P/E ratio 2017 34,03
EV / Sales 2016 9,49x
EV / Sales 2017 8,51x
Capitalization 26 536 M
More Financials
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICA...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 742 $
Spread / Average Target 7,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL, IN..26.22%26 536
THERMO FISHER SCIENTIF..10.60%61 738
BOSTON SCIENTIFIC CORP..29.72%32 456
PHILIPS0.96%24 759
EDWARDS LIFESCIENCES C..34.53%22 500
ILLUMINA, INC.-21.46%22 192
More Results